Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
{{output}}
Introduction: Immune-checkpoint inhibitors (ICIs) are transforming the modern era of cancer therapy. As new treatment options are becoming available, new patterns of disease behavior are manifesting. One such phenomenon, known as... ...